Rhenman & Partners Asset Management AB cut its holdings in Insulet Co. (NASDAQ:PODD – Free Report) by 56.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 19,000 shares of the medical instruments supplier’s stock after selling 25,000 shares during the period. Rhenman & Partners […]
Equities researchers at Redburn Atlantic began coverage on shares of Insulet (NASDAQ:PODD – Get Free Report) in a report issued on Thursday, MarketBeat Ratings reports. The firm set a “buy” rating and a $235.00 price target on the medical instruments supplier’s stock. Redburn Atlantic’s price target would indicate a potential upside of 32.63% from the […]
Allianz Asset Management GmbH boosted its holdings in Insulet Co. (NASDAQ:PODD – Free Report) by 85.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 108,109 shares of the medical instruments supplier’s stock after acquiring an additional 49,715 shares during the period. […]
Artisan Partners Limited Partnership lowered its position in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 2.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 180,199 shares of the medical instruments supplier’s stock after selling 4,485 shares during the period. […]
Insulet Co. (NASDAQ:PODD – Get Free Report) Director Timothy J. Scannell sold 3,300 shares of the stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $180.90, for a total transaction of $596,970.00. Following the sale, the director now owns 42,586 shares in the company, valued […]